![Zhui Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zhui Chen
Plus aucun poste en cours
Fortune : 24 M $ au 30/06/2026
Profil
Zhui Chen is the founder of Abbisko Cayman Ltd., founded in 2016, holding the title of Executive Director & Senior Vice President-Biology from 2018 to 2025.
Dr. Chen is the founder of Abbisko Therapeutics Co., Ltd., founded in 2016, holding the title of Chief Scientific Officer.
Current jobs include Chief Executive Officer at Otr Therapeutics Ltd. since 2025, Director at Abbisko Hong Kong Ltd. since 2018, Independent Non-Executive Director at Alebund Pharmaceuticals (Jiangsu) Ltd. since 2025, and Member of the American Association for Cancer Research since 2007.
Former job includes Associate Director at Johnson & Johnson China Ltd. from 2014 to 2016.
Education includes a doctorate from Duke University conferred in 2003 and an undergraduate degree from The University of Texas at Austin conferred in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ABBISKO CAYMAN LIMITED 2,38 % | 30/06/2025 | 17 207 394 ( 2,38 % ) | 24 M $ | 30/06/2026 |
Postes actifs de Zhui Chen
| Sociétés | Poste | Début |
|---|---|---|
Abbisko Hong Kong Ltd. | Directeur/Membre du Conseil | 01/03/2018 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Corporate Officer/Principal | 01/01/2007 |
Anciens postes connus de Zhui Chen
| Sociétés | Poste | Fin |
|---|---|---|
| ABBISKO CAYMAN LIMITED | Fondateur | 03/03/2025 |
Johnson & Johnson China Ltd.
 Johnson & Johnson China Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 01/05/2016 |
Abbisko Therapeutics Co., Ltd.
 Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Fondateur | - |
Formation de Zhui Chen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
99
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
Johnson & Johnson China Ltd.
Johnson & Johnson China Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Health Technology |
Abbisko Cayman Ltd.
 Abbisko Cayman Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to the discovery and development of small molecule oncology therapies | Health Technology |
Abbisko Hong Kong Ltd. |
Choisissez Zonebourse 
